Thread: Yahoo- Lexicon Initiates Phase 2 Clinical Trial Of LX1032 In Patients WithCarcinoid Syndrome (Medical News Today)  |
|||||||||||||
|
Started 8 months, 2 weeks ago by IBSGroupster
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has initiated a Phase 2 clinical trial of LX1032, the company's oral drug candidate for managing gastrointestinal symptoms associated with carcinoid syndrome. View the full article
|
|
||||||||||||
|
|||||||||||||
Related threads on "IBS Self Help and Support Group Forums": |
Related threads on other sites: |
||||||||||||
Thread profile page for "Yahoo- Lexicon Initiates Phase 2 Clinical Trial Of LX1032 In Patients WithCarcinoid Syndrome (Medical News Today)" on http://www.ibsgroup.org.
This report page is a snippet summary view from a single thread "Yahoo- Lexicon Initiates Phase 2 Clinical Trial Of LX1032 In Patients WithCarcinoid Syndrome (Medical News Today)", located on the Message Board at http://www.ibsgroup.org.
This thread profile page shows the thread statistics for: Total Authors, Total Thread Posts, and Thread Activity
Home |
About Us |
Submit Your Site |
Update Your Site |
Get Search For Your Site |
Partners |
Contact |
Search Plugin |
Blog |
 |
Last Searches | Top Searches |
Designated brands and trademarks are property of their respective owners.
Use of this website constitutes acceptance of BoardReader's User Agreement and Privacy Policy.